Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic factors influencing diabetes drugs 3
2006-002835-25Phase 4Completed
- Sponsor
- Clinical Pharmacology Unit, University of Turku
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of repaglinide and nateglinide in type 2 diabetes mellitus (T2DM), sponsored by Clinical Pharmacology Unit, University of Turku. Started May 2006; status: completed.
02
Drugs
repaglinidenateglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002835-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002835-25.